Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Ching-Yuan Chang

Biographic Data

ID5534453
NAMEChing-Yuan Chang
GIVEN NAMESChing-Yuan
FAMILY NAMEChang
SIGNATURECHANG C
AFFILIATIONSDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C

    Xinyi Jiang, Hyun Jin Song et al.•ARTICLE•Medical Care•2023•References: 33

    OBJECTIVE: The effects of all-oral direct-acting antivirals (DAAs) on hepatocellular carcinoma (HCC) and liver-related and all-cause mortality were assessed among Medicaid beneficiaries with hepatitis C virus (HCV). SUBJECTS: This cohort study used 2013-2019 Arizona Medicaid data from beneficiaries with HCV aged 18-64 years. METHODS: Risks of HCC and liver-related and all-cause mortality were compared between patients with or without DAA treatmen…

  • Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

    Xinyi Jiang, Hyun Jin Song et al.•ARTICLE•Medical Care•2023•References: 13

    BACKGROUND: High costs of direct-acting antivirals (DAAs) have led to their restricted access for patients with hepatitis C virus (HCV). OBJECTIVE: The aim was to assess how HCV treatment access and predictors of HCV treatment changed in the post-DAA period compared with pre-DAA period. METHODS: A retrospective cohort study using Arizona Medicaid data was conducted for patients with HCV to compare treatment initiation rates between pre-DAA (Janua…

  • Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia

    Open Access•Ching-Yuan Chang, Ching‐Yuan Chang et al.•ARTICLE•INQUIRY The Journal of Health…•2021

    The results from previous observational studies and clinical trials about the neuroprotective benefits of statins use for the prevention of dementia are contradictory. It is unclear whether the neuroprotective benefits are experienced in a specific group with a higher risk of dementia, such as patients with concurrent diabetes and hyperlipidemia. We aimed to examine the association between adherence to statins and the risk of dementia among patie…

No prominent works on this page.

  • Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia

    Open Access•Ching-Yuan Chang, Ching‐Yuan Chang et al.•ARTICLE•INQUIRY The Journal of Health…•2021

    The results from previous observational studies and clinical trials about the neuroprotective benefits of statins use for the prevention of dementia are contradictory. It is unclear whether the neuroprotective benefits are experienced in a specific group with a higher risk of dementia, such as patients with concurrent diabetes and hyperlipidemia. We aimed to examine the association between adherence to statins and the risk of dementia among patie…

  • Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C

    Xinyi Jiang, Hyun Jin Song et al.•ARTICLE•Medical Care•2023•References: 33

    OBJECTIVE: The effects of all-oral direct-acting antivirals (DAAs) on hepatocellular carcinoma (HCC) and liver-related and all-cause mortality were assessed among Medicaid beneficiaries with hepatitis C virus (HCV). SUBJECTS: This cohort study used 2013-2019 Arizona Medicaid data from beneficiaries with HCV aged 18-64 years. METHODS: Risks of HCC and liver-related and all-cause mortality were compared between patients with or without DAA treatmen…

  • Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

    Xinyi Jiang, Hyun Jin Song et al.•ARTICLE•Medical Care•2023•References: 13

    BACKGROUND: High costs of direct-acting antivirals (DAAs) have led to their restricted access for patients with hepatitis C virus (HCV). OBJECTIVE: The aim was to assess how HCV treatment access and predictors of HCV treatment changed in the post-DAA period compared with pre-DAA period. METHODS: A retrospective cohort study using Arizona Medicaid data was conducted for patients with HCV to compare treatment initiation rates between pre-DAA (Janua…

Internal Medicine (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Cohort (2 works) · Confidence interval (2 works) · Hazard ratio (2 works) · Hepatitis C (2 works) · Hepatitis C virus research (2 works) · Medicaid (2 works) · Cirrhosis (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae